Even though MTHFR mutation testing is not part of the routine assessment, since it has a limited predictive value when present by itself, the coexistence of it with other prothrombotic factors, such as protein S deficiency, increases its clinical significance. The gene discussed is PROS1; the disease is hyperinsulinemic hypoglycemia, familial, 4.